MoneyWorks4Me

Lupin informs about press release

17 Mar 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, receipt of tentative approval from the U.S. FDA for the Company’s Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..